These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 12971827)

  • 1. Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study.
    Wojcicki JM; Newton R; Urban MI; Stein L; Hale M; Patel M; Ruff P; Sur R; Bourboulia D; Sitas F
    BMC Infect Dis; 2003 Sep; 3():21. PubMed ID: 12971827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against human herpesvirus 8 in black South African patients with cancer.
    Sitas F; Carrara H; Beral V; Newton R; Reeves G; Bull D; Jentsch U; Pacella-Norman R; Bourboulia D; Whitby D; Boshoff C; Weiss R
    N Engl J Med; 1999 Jun; 340(24):1863-71. PubMed ID: 10369849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of the frequency of antibody and titers against human herpesvirus 8 latent and lytic antigens in "at-risk" individuals and among patients with Kaposi's sarcoma.
    Magri MC; Carbone PH; de los Santos-Fortuna E; Caterino-de-Araujo A
    J Med Virol; 2009 Jul; 81(7):1292-7. PubMed ID: 19475629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
    Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
    Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of antibodies against latent and lytic antigens of human herpesvirus 8 in an endemic population and patients with Kaposi's sarcoma in Mozambique.
    Caterino-de-Araujo A; Magri MC; Manuel RC
    J Med Virol; 2010 Sep; 82(9):1576-81. PubMed ID: 20648612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N; Spira T; Lam L; Corchero JL; Luo W
    J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroreactivity to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent nuclear antigen in AIDS-associated Kaposi's sarcoma patients depends on CD4+ T-cell count.
    de Souza VA; Pierrotti LC; Sumita LM; Freire WS; Segurado AA; Pannuti CS
    J Med Virol; 2007 Oct; 79(10):1562-8. PubMed ID: 17705173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda.
    Newton R; Ziegler J; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):226-32. PubMed ID: 12455037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of human herpesvirus 8 infection in individuals from health care centers in Mozambique: potential for endemic and epidemic Kaposi's sarcoma.
    Caterino-de-Araujo A; Manuel RC; Del Bianco R; Santos-Fortuna E; Magri MC; Silva JM; Bastos R
    J Med Virol; 2010 Jul; 82(7):1216-23. PubMed ID: 20513087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda.
    Ziegler J; Newton R; Bourboulia D; Casabonne D; Beral V; Mbidde E; Carpenter L; Reeves G; Parkin DM; Wabinga H; Mbulaiteye S; Jaffe H; Weiss R; Boshoff C;
    Int J Cancer; 2003 Jan; 103(2):233-40. PubMed ID: 12455038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8.
    Ariyoshi K; Schim van der Loeff M; Cook P; Whitby D; Corrah T; Jaffar S; Cham F; Sabally S; O'Donovan D; Weiss RA; Schulz TF; Whittle H
    J Hum Virol; 1998; 1(3):193-9. PubMed ID: 10195242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women.
    Greenblatt RM; Jacobson LP; Levine AM; Melnick S; Anastos K; Cohen M; DeHovitz J; Young MA; Burns D; Miotti P; Koelle DM
    J Infect Dis; 2001 Apr; 183(7):1130-4. PubMed ID: 11237842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human herpesvirus 8 presence and viral load are associated with the progression of AIDS-associated Kaposi's sarcoma.
    Laney AS; Cannon MJ; Jaffe HW; Offermann MK; Ou CY; Radford KW; Patel MM; Spira TJ; Gunthel CJ; Pellett PE; Dollard SC
    AIDS; 2007 Jul; 21(12):1541-5. PubMed ID: 17630548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
    Lennette ET; Blackbourn DJ; Levy JA
    Lancet; 1996 Sep; 348(9031):858-61. PubMed ID: 8826812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological characteristics of human herpesvirus-8 infection in a large population of antenatal women in Zambia.
    Klaskala W; Brayfield BP; Kankasa C; Bhat G; West JT; Mitchell CD; Wood C
    J Med Virol; 2005 Jan; 75(1):93-100. PubMed ID: 15543582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.
    Melbye M; Cook PM; Hjalgrim H; Begtrup K; Simpson GR; Biggar RJ; Ebbesen P; Schulz TF
    Int J Cancer; 1998 Aug; 77(4):543-8. PubMed ID: 9679756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women.
    Kedes DH; Ganem D; Ameli N; Bacchetti P; Greenblatt R
    JAMA; 1997 Feb; 277(6):478-81. PubMed ID: 9020272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demographic indicators and risk of infection with human herpesvirus type 8 in Central Italy.
    Valdarchi C; Serraino D; Cordiali Fei P; Castilletti C; Trento E; Farchi F; Rezza G;
    Infection; 2007 Feb; 35(1):22-5. PubMed ID: 17297585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual transmission and the natural history of human herpesvirus 8 infection.
    Martin JN; Ganem DE; Osmond DH; Page-Shafer KA; Macrae D; Kedes DH
    N Engl J Med; 1998 Apr; 338(14):948-54. PubMed ID: 9521982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus 8: serovprevalence and correlates in tumor patients from Xinjiang, China.
    He F; Wang X; He B; Feng Z; Lu X; Zhang Y; Zhao S; Lin R; Hui Y; Bao Y; Zhang Z; Wen H
    J Med Virol; 2007 Feb; 79(2):161-6. PubMed ID: 17177299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.